Case Comprehensive Cancer Center

Did you ever wonder how our colleagues nationally get to know us? As we enter 2017, I have one answer for you - the core grant renewal for the Case Comprehensive Cancer Center. The number of leaders in the field of cancer research who will learn about us through the grant renewal is daunting! Ou...

I would like to alert our membership of the two-year initiative I set out for the Association of American Cancer Institutes (AACI) at the national meeting last week. As President of AACI for the next two years, I asked all the cancer centers to participate in a review of practices and approaches to...

A multi-institution academic-industrial partnership of researchers led by Case Western Reserve University School of Medicine has developed a new method to broadly assess cell communication networks and identify disease-specific network anomalies. The computer-based method, called InFlo, was develope...

Guest Commentary: Megan Kilbane, MBA, Assistant Dean for Oncology 2016 has been described as the year of 216, and it would be hard for anyone to argue that it is not truly the year for Cleveland to shine. From the Cavs to the Monsters and soon to be the Indians, we are grabbing championships left ...

Monica Webb Hooper, director of the Office of Cancer Disparities Research at the Case Comprehensive Cancer Center in the Case Western Reserve University School of Medicine, will give a lecture titled “Cancer Disparities Among Women: The Role of Tobacco Use.” Hosted by the Flora Stone Mather Center ...

Results reported by University Hospitals Cleveland Medical Center Neurosurgeon Andrew Sloan, MD & colleagues Andrew SloanA new paper in the October issue of the journal Neurosurgical Focus finds the use of laser beneficial for the removal of large, "inoperable" glioblastoma (GBM) and other types of...

Quick and automated count of tubules correlates with current best—but expensive— genomic test determining who needs chemotherapy and who doesn’t The number of tubules in tumors may predict which women with estrogen receptor positive (ER+) breast cancer will benefit from hormone therapy alone and whi...

Invited commentary by Drs. Paula Silverman and Cheryl Thompson A recent study by Jones et al. in The British Journal of Cancer (BJC)(Jones ME. Br J Cancer. 2016 Aug 23) estimated an almost 3 fold (2.74 times) increase risk of breast cancer among post-menopausal women who used combination estrogen ...

15 gene mutations lead to higher recurrence and metastasis; genes may contribute to lower survival rates seen in African-Americans Case Comprehensive Cancer Center researchers, a research collaboration which includes University Hospitals Seidman Cancer Center and Case Western Reserve University, wh...

Case Comprehensive Cancer Center researchers identify several structurally abnormal genes in esophageal adenocarcinoma in first ever genome-wide search Despite years of research, cellular mechanisms contributing to cancers like esophageal adenocarcinoma have remained elusive. What has puzzled resea...